A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disease with few effective therapeutic options. Recently, drug repositioning, which involves identifying novel therapeutic potentials for existing drugs, has been popularized as a new approach for the development of novel thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Imakura, Takeshi, Sato, Seidai, Koyama, Kazuya, Ogawa, Hirohisa, Niimura, Takahiro, Murakami, Kojin, Yamashita, Yuya, Haji, Keiko, Naito, Nobuhito, Kagawa, Kozo, Kawano, Hiroshi, Zamami, Yoshito, Ishizawa, Keisuke, Nishioka, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236721/
https://www.ncbi.nlm.nih.gov/pubmed/37269004
http://dx.doi.org/10.1186/s12931-023-02446-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236721/
https://www.ncbi.nlm.nih.gov/pubmed/37269004
http://dx.doi.org/10.1186/s12931-023-02446-x

Ejemplares similares